Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT
Recruiting
Conditions
Letemovir for the Prevention of CMV Infection After Allo-HSCT
Interventions
Drug: Letermovir
Subscribe
First Posted Date
2024-03-12
Last Posted Date
2024-03-12
Lead Sponsor
Cao Weijie
Target Recruit Count
150
Registration Number
NCT06306989
Locations
🇨🇳
Cao, Weijie, Zhengzhou, Henan, China
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy